ENTRY       D11945                      Drug
NAME        Mezagitamab (USAN/INN)
FORMULA     C6402H9884N1720O2024S42
EXACT_MASS  144587.1641
MOL_WEIGHT  144676.02
SEQUENCE    (Heavy chain)
            EVQLLESGGG LVQPGGSLRL SCAASGFTFD DYGMSWVRQA PGKGLEWVSD ISWNGGKTHY
            VDSVKGQFTI SRDNSKNTLY LQMNSLRAED TAVYYCARGS LFHDSSGFYF GHWGQGTLVT
            VSSASTKGPS VFPLAPSSKS TSGGTAALGC LVKDYFPEPV TVSWNSGALT SGVHTFPAVL
            QSSGLYSLSS VVTVPSSSLG TQTYICNVNH KPSNTKVDKR VEPKSCDKTH TCPPCPAPEL
            LGGPSVFLFP PKPKDTLMIS RTPEVTCVVV DVSHEDPEVK FNWYVDGVEV HNAKTKPREE
            QYNSTYRVVS VLTVLHQDWL NGKEYKCKVS NKALPAPIEK TISKAKGQPR EPQVYTLPPS
            REEMTKNQVS LTCLVKGFYP SDIAVEWESN GQPENNYKTT PPVLDSDGSF FLYSKLTVDK
            SRWQQGNVFS CSVMHEALHN HYTQKSLSLS PGK
            (Light chain)
            QSVLTQPPSA SGTPGQRVTI SCSGSSSNIG DNYVSWYQQL PGTAPKLLIY RDSQRPSGVP
            DRFSGSKSGT SASLAISGLR SEDEADYYCQ SYDSSLSGSV FGGGTKLTVL GQPKANPTVT
            LFPPSSEELQ ANKATLVCLI SDFYPGAVTV AWKADGSPVK AGVETTKPSK QSNNKYAASS
            YLSLTPEQWK SHRSYSCQVT HEGSTVEKTV APTECS
            (Disulfide bridge: H22-H96,  H150-H206, H226-L215, H232-H'232, H235-H'235, H267-H327, H373-H431, H'22-H'96, H'150-H'206, H'226-L'215, H'267-H'327, H'373-H'431, L22-L89, L138-L197, L'22-L'89, L'138-L'197)
  TYPE      Peptide
EFFICACY    Antineoplasitc, Immunomodulator, Anti-CD38 antibody
  TYPE      Monoclonal antibody
TARGET      CD38 [HSA:952] [KO:K01242]
  PATHWAY   hsa04640(952)  Hematopoietic cell lineage
BRITE       Target-based classification of drugs [BR:br08310]
             Enzymes
              Hydrolases (EC3)
               ADP-ribosyl cyclase
                CD38
                 D11945  Mezagitamab (USAN/INN)
DBLINKS     CAS: 2227490-52-8
///
